Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms
2011-01-01 Pietra, D; Brisci, A; Rumi, E; Boggi, S; Elena, C; Pietrelli, A; Bordoni, R; Ferrari, M; Passamonti, Francesco; De Bellis, G; Cremonesi, L; Cazzola, M.
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
2011-01-01 Passamonti, Francesco; Elena, C; Schnittger, S; Skoda, Rc; Green, Ar; Girodon, F; Kiladjian, Jj; Mcmullin, Mf; Ruggeri, M; Besses, C; Vannucchi, Am; Lippert, E; Gisslinger, H; Rumi, E; Lehmann, T; Ortmann, Ca; Pietra, D; Pascutto, C; Haferlach, T; Cazzola, M.
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
2011-01-01 Barbui, T; Thiele, J; Passamonti, Francesco; Rumi, E; Boveri, E; Ruggeri, M; Rodeghiero, F; D'Amore, Es; Randi, Ml; Bertozzi, I; Marino, F; Vannucchi, Am; Antonioli, E; Carrai, V; Gisslinger, H; Buxhofer Ausch, V; Müllauer, L; Carobbio, A; Gianatti, A; Gangat, N; Hanson, Ca; Tefferi, A.
The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms.
2011-01-01 Olcaydu, D; Rumi, E; Harutyunyan, A; Passamonti, Francesco; Pietra, D; Pascutto, C; Berg, T; Jäger, R; Hammond, E; Cazzola, M; Kralovics, R.
Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients.
2011-01-01 Rumi, E; Passamonti, Francesco; Elena, C; Pietra, D; Arcaini, L; Astori, C; Zibellini, S; Boveri, E; Pascutto, C; Lazzarino, M.
Leukemic transformation of polycythemia vera: a single center study of 23 patients
2005-01-01 Passamonti, Francesco; Rumi, E; Arcaini, L; Castagnola, C; Lunghi, M; Bernasconi, P; Della Porta, Mg; Columbo, N; Pascutto, C; Cazzola, M; Lazzarino, M.
Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2
2005-01-01 Kralovics, R; Teo, Ss; Buser, As; Brutsche, M; Tiedt, R; Tichelli, A; Passamonti, Francesco; Pietra, D; Cazzola, M; Skoda, Rc
Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm
2011-01-01 Rumi, E; Harutyunyan, A; Elena, C; Pietra, D; Klampfl, T; Bagienski, K; Berg, T; Casetti, I; Pascutto, C; Passamonti, Francesco; Kralovics, R; Cazzola, M.
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia
2005-01-01 Passamonti, Francesco; Pietra, D; Rumi, E; Arcaini, L; Della Porta, Mg; Malcovati, L; Pascutto, C; Lazzarino, M; Cazzola, M.
Pityriasis roseaelike eruption during treatment with imatinib mesylate: Description of 3 cases
2005-01-01 Brazzelli, V; Prestinari, F; Roveda, E; Barbagallo, T; Bellani, E; Vassallo, C; Orlandi, E; Passamonti, Francesco; Borroni, G.
Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis.
2010-01-01 Passamonti, Francesco; Cervantes, F; Vannucchi, Am; Morra, E; Rumi, E; Cazzola, M; Tefferi, A.
Mutational status of myeloproliferative neoplasms.
2010-01-01 Rumi, E; Elena, C; Passamonti, Francesco
Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence.
2010-01-01 Passamonti, Francesco; Rumi, E; Elena, C; Arcaini, L; Merli, M; Pascutto, C; Cazzola, M; Lazzarino, M.
Risk of second cancer in nongastric marginal zone B-cell lymphomas of MALT: a population-based study from Northern Italy
2007-01-01 Arcaini, L.; Burcheri, S.; Rossi, A.; Pascutto, C.; Passamonti, Francesco; Brusamolino, E.; Paulli, M.; Orlandi, E.; Buelli, M.; Viero, P.; Lucioni, M.; Montanari, F.; Merli, M.; Cortelazzo, S.; Lazzarino, M.
Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
2007-01-01 Arcaini, L; Burcheri, S; Rossi, A; Paulli, M; Bruno, R; Passamonti, Francesco; Brusamolino, E; Molteni, A; Pulsoni, A; Cox, Mc; Orsucci, L; Fabbri, A; Frezzato, M; Voso, Mt; Zaja, F; Montanari, F; Merli, M; Pascutto, C; Morra, E; Cortelazzo, S; Lazzarino, M.
Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients
2009-01-01 Boveri, E; Arcaini, L; Merli, M; Passamonti, Francesco; Rizzi, S; Vanelli, L; Rumi, E; Rattotti, S; Lucioni, M; Picone, C; Castello, A; Pascutto, C; Lazzarino, M; Magrini, U; Paulli, M.
Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment
2006-01-01 Arcaini, L; Colombo, N; Passamonti, Francesco; Burcheri, S; Orlandi, E; Brusamolino, E; Della Porta, M; Rumi, E; Montanari, F; Pascutto, C; Paulli, M; Lazzarino, M.
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
2008-01-01 Barosi, G; Mesa, Ra; Thiele, J; Cervantes, F; Campbell, Pj; Verstovsek, S; Dupriez, B; Levine, Rl; Passamonti, Francesco; Gotlib, J; Reilly, Jt; Vannucchi, Am; Hanson, Ca; Solberg, La; Orazi, A; Tefferi, A.
Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up
2006-01-01 Brusamolino, E; Baio, A; Orlandi, E; Arcaini, L; Passamonti, Francesco; Griva, V; Casagrande, W; Pascutto, C; Franchini, P; Lazzarino, M.
Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases
2005-01-01 Vassallo, C; Passamonti, Francesco; Cananzi, R; Brazzelli, V; Ardigò, M; Lazzarino, M; Borroni, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Deep sequencing reveals double mutations in cis of MPL exon 10 in myeloproliferative neoplasms | 1-gen-2011 | Pietra, D; Brisci, A; Rumi, E; Boggi, S; Elena, C; Pietrelli, A; Bordoni, R; Ferrari, M; Passamonti, Francesco; De Bellis, G; Cremonesi, L; Cazzola, M. | |
| Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations. | 1-gen-2011 | Passamonti, Francesco; Elena, C; Schnittger, S; Skoda, Rc; Green, Ar; Girodon, F; Kiladjian, Jj; Mcmullin, Mf; Ruggeri, M; Besses, C; Vannucchi, Am; Lippert, E; Gisslinger, H; Rumi, E; Lehmann, T; Ortmann, Ca; Pietra, D; Pascutto, C; Haferlach, T; Cazzola, M. | |
| Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. | 1-gen-2011 | Barbui, T; Thiele, J; Passamonti, Francesco; Rumi, E; Boveri, E; Ruggeri, M; Rodeghiero, F; D'Amore, Es; Randi, Ml; Bertozzi, I; Marino, F; Vannucchi, Am; Antonioli, E; Carrai, V; Gisslinger, H; Buxhofer Ausch, V; Müllauer, L; Carobbio, A; Gianatti, A; Gangat, N; Hanson, Ca; Tefferi, A. | |
| The role of the JAK2 GGCC haplotype and the TET2 gene in familial myeloproliferative neoplasms. | 1-gen-2011 | Olcaydu, D; Rumi, E; Harutyunyan, A; Passamonti, Francesco; Pietra, D; Pascutto, C; Berg, T; Jäger, R; Hammond, E; Cazzola, M; Kralovics, R. | |
| Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients. | 1-gen-2011 | Rumi, E; Passamonti, Francesco; Elena, C; Pietra, D; Arcaini, L; Astori, C; Zibellini, S; Boveri, E; Pascutto, C; Lazzarino, M. | |
| Leukemic transformation of polycythemia vera: a single center study of 23 patients | 1-gen-2005 | Passamonti, Francesco; Rumi, E; Arcaini, L; Castagnola, C; Lunghi, M; Bernasconi, P; Della Porta, Mg; Columbo, N; Pascutto, C; Cazzola, M; Lazzarino, M. | |
| Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2 | 1-gen-2005 | Kralovics, R; Teo, Ss; Buser, As; Brutsche, M; Tiedt, R; Tichelli, A; Passamonti, Francesco; Pietra, D; Cazzola, M; Skoda, Rc | |
| Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm | 1-gen-2011 | Rumi, E; Harutyunyan, A; Elena, C; Pietra, D; Klampfl, T; Bagienski, K; Berg, T; Casetti, I; Pascutto, C; Passamonti, Francesco; Kralovics, R; Cazzola, M. | |
| PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia | 1-gen-2005 | Passamonti, Francesco; Pietra, D; Rumi, E; Arcaini, L; Della Porta, Mg; Malcovati, L; Pascutto, C; Lazzarino, M; Cazzola, M. | |
| Pityriasis roseaelike eruption during treatment with imatinib mesylate: Description of 3 cases | 1-gen-2005 | Brazzelli, V; Prestinari, F; Roveda, E; Barbagallo, T; Bellani, E; Vassallo, C; Orlandi, E; Passamonti, Francesco; Borroni, G. | |
| Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis. | 1-gen-2010 | Passamonti, Francesco; Cervantes, F; Vannucchi, Am; Morra, E; Rumi, E; Cazzola, M; Tefferi, A. | |
| Mutational status of myeloproliferative neoplasms. | 1-gen-2010 | Rumi, E; Elena, C; Passamonti, Francesco | |
| Incidence of leukaemia in patients with primary myelofibrosis and RBC-transfusion-dependence. | 1-gen-2010 | Passamonti, Francesco; Rumi, E; Elena, C; Arcaini, L; Merli, M; Pascutto, C; Cazzola, M; Lazzarino, M. | |
| Risk of second cancer in nongastric marginal zone B-cell lymphomas of MALT: a population-based study from Northern Italy | 1-gen-2007 | Arcaini, L.; Burcheri, S.; Rossi, A.; Pascutto, C.; Passamonti, Francesco; Brusamolino, E.; Paulli, M.; Orlandi, E.; Buelli, M.; Viero, P.; Lucioni, M.; Montanari, F.; Merli, M.; Cortelazzo, S.; Lazzarino, M. | |
| Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT | 1-gen-2007 | Arcaini, L; Burcheri, S; Rossi, A; Paulli, M; Bruno, R; Passamonti, Francesco; Brusamolino, E; Molteni, A; Pulsoni, A; Cox, Mc; Orsucci, L; Fabbri, A; Frezzato, M; Voso, Mt; Zaja, F; Montanari, F; Merli, M; Pascutto, C; Morra, E; Cortelazzo, S; Lazzarino, M. | |
| Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients | 1-gen-2009 | Boveri, E; Arcaini, L; Merli, M; Passamonti, Francesco; Rizzi, S; Vanelli, L; Rumi, E; Rattotti, S; Lucioni, M; Picone, C; Castello, A; Pascutto, C; Lazzarino, M; Magrini, U; Paulli, M. | |
| Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment | 1-gen-2006 | Arcaini, L; Colombo, N; Passamonti, Francesco; Burcheri, S; Orlandi, E; Brusamolino, E; Della Porta, M; Rumi, E; Montanari, F; Pascutto, C; Paulli, M; Lazzarino, M. | |
| Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment | 1-gen-2008 | Barosi, G; Mesa, Ra; Thiele, J; Cervantes, F; Campbell, Pj; Verstovsek, S; Dupriez, B; Levine, Rl; Passamonti, Francesco; Gotlib, J; Reilly, Jt; Vannucchi, Am; Hanson, Ca; Solberg, La; Orazi, A; Tefferi, A. | |
| Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up | 1-gen-2006 | Brusamolino, E; Baio, A; Orlandi, E; Arcaini, L; Passamonti, Francesco; Griva, V; Casagrande, W; Pascutto, C; Franchini, P; Lazzarino, M. | |
| Exaggerated insect bite-like reaction in patients affected by oncohaematological diseases | 1-gen-2005 | Vassallo, C; Passamonti, Francesco; Cananzi, R; Brazzelli, V; Ardigò, M; Lazzarino, M; Borroni, G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Articoli su Riviste35263
Data di pubblicazione
- In corso di stampa26
- 2020 - 202710432
- 2010 - 201911845
- 2000 - 20097910
- 1990 - 19993628
- 1980 - 19891162
- 1970 - 1979252
- 1967 - 19698
Editore
- Edizioni Luigi Pozzi Srl:via Pana...51
- Japadre Editore, L'Aquila36
- WILEY34
- Elsevier BV:PO Box 211, 1000 AE A...31
- ELSEVIER SCIENCE BV29
- Franco Angeli Riviste SRL:viale M...28
- Springer Verlag Germany:Tiergarte...28
- -Roma: [s.n.]. -Artegierre-Esseze...26
- Elsevier B.V.23
- Royal Society of Chemistry:Thomas...21
Rivista
- PHYSICAL REVIEW LETTERS216
- LA RADIOLOGIA MEDICA180
- NUCLEAR INSTRUMENTS & METHODS IN ...176
- ASTRONOMY & ASTROPHYSICS168
- MONTHLY NOTICES OF THE ROYAL ASTR...165
- PLOS ONE163
- PHYSICS LETTERS. SECTION B154
- SCIENTIFIC REPORTS153
- THROMBOSIS AND HAEMOSTASIS145
- IL PROTAGORA140
Serie
- PROCEEDINGS OF INTERNATIONAL MATH...1
Keyword
- Humans1627
- Female817
- Male695
- Middle Aged526
- COVID-19518
- Aged481
- Adult464
- Italy345
- SARS-CoV-2317
- Treatment Outcome240
Lingua
- eng18885
- ita2906
- fre60
- spa55
- ger35
- por14
- bul9
- rus8
- gre6
- chi3
Accesso al fulltext
- no fulltext24730
- reserved5245
- open5085
- restricted107
- partially open93
- mixed2
- embargoed1